Skip to main content
Retour
Watch Compare

CalciMedica, Inc.

Qualité des données : 83%
CALC
Nasdaq Manufacturing Chemicals
0,66 €
▲ 0,04 € (6,42%)
Cap. Boursière: 10,44 M
Prix
0,66 €
Cap. Boursière
10,44 M
Fourchette du Jour
0,61 € — 0,70 €
Fourchette 52 Semaines
0,46 € — 7,20 €
Volume
434 085
Ouverture 0,62 €
Moyenne 50J / 200J
0,94 €
29,20% below
Moyenne 50J / 200J
2,86 €
76,81% below

Quick Summary

Points Clés

Negative free cash flow of -21,21 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-1013,26%
En dessous de la moyenne du secteur (-51,02%)
ROIC-136,13%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio4,04
Interest Coverage-16,26

Valorisation

PE (TTM)
-0,35
Au-dessus de la moyenne du secteur (-1,98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -0,4 -2,0
P/B — 5,1
ROE % -1013,3 -51,0
Net Margin % — -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -29,56 M
ROE -1013,26% ROA -173,93%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -21,21 M
ROIC -136,13% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,04
Interest Coverage -16,26 Asset Turnover N/A
Working Capital 11,17 M Tangible Book Value -268 000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,35 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -203,22%
Market Cap 10,44 M Enterprise Value 4,97 M
Per Share
EPS (Diluted TTM) -1,97 Revenue / Share N/A
FCF / Share -1,35 OCF / Share -1,35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 71,73%
SBC-Adj. FCF -24,34 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -29,56 M -13,70 M -34,36 M -35,61 M -35,82 M
EPS (Diluted) -1,97 -1,22 -7,66 -1,66 —
Gross Profit — — — — —
Operating Income -23,12 M -24,20 M -38,08 M -36,18 M -35,95 M
EBITDA — — — — —
R&D Expenses 15,23 M 14,48 M 15,86 M 14,11 M 18,90 M
SG&A Expenses — — — — —
D&A — — 58 000,0 — —
Interest Expense 1,42 M — — — —
Income Tax 0,0 0,0 1 000,0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 13,59 M 19,79 M 12,19 M 39,67 M 69,09 M
Total Liabilities 20,23 M 5,38 M 4,03 M 3,70 M 4,07 M
Shareholders' Equity -6,64 M 14,41 M 8,16 M 35,97 M 65,02 M
Total Debt — — — — —
Cash & Equivalents 11,52 M 7,94 M 5,53 M 17,30 M 13,36 M
Current Assets 13,53 M 19,67 M 11,61 M 39,67 M 67,08 M
Current Liabilities 3,78 M 3,68 M 4,03 M 3,70 M 4,06 M